NasdaqCM - Delayed Quote USD
NKGen Biotech, Inc. (NKGNW)
0.0900
-0.0050
(-5.26%)
At close: June 11 at 3:38:15 PM EDT
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
16,481
16,330
18,070
Total Liabilities Net Minority Interest
75,174
14,767
56,122
Total Equity Gross Minority Interest
-58,693
1,563
-38,052
Total Capitalization
-48,763
1,563
-38,052
Common Stock Equity
-58,693
1,563
-38,052
Capital Lease Obligations
0
379
818
Net Tangible Assets
-58,785
1,466
-38,141
Working Capital
-37,522
-14,391
-55,131
Invested Capital
-38,772
13,218
13,101
Tangible Book Value
-58,785
1,466
-38,141
Total Debt
19,921
12,034
51,971
Net Debt
19,895
11,538
50,802
Share Issued
21,888.9760
21,888.9760
21,888.9760
Ordinary Shares Number
21,888.9760
21,888.9760
21,888.9760
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2LB.MU Iovance Biotherapeutics Inc
1.9688
0.00%
N04.MU Nucana PLC R
0.1040
-20.00%
N04.SG Nucana PLC (ADRs)
0.0970
-22.40%
2LB.SG Iovance Biotherapeutics Inc
1.9208
-1.05%
2LB.BE Iovance Biotherapeutics Inc
1.9324
+1.19%
2LB.DU Iovance Biotherapeutics Inc
1.9544
+1.54%
N04.BE Nucana PLC R
0.1030
-23.13%
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
N04.F NuCana plc
0.1020
-33.77%
PHRM.CN PharmaTher Holdings Ltd.
0.2300
+12.20%